← The Wire
AKBANasdaq
Akebia Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1517022
Develops and commercializes innovative therapeutics for patients impacted by kidney disease
$248M
Market cap
$1.11
Last close
-2.6%
1D
+1.8%
5D
3.6M
Volume
Price · last 39 sessions-26.0%
May 4L $0.87 · H $1.50Jun 29
324
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 22, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KExecutive ChangeApr 1, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KExecutive Change · Material AgreementJan 30, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KMaterial Agreement · Reg FD DisclosureDec 1, 20258-KMaterial AgreementNov 17, 202510-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KReg FD Disclosure · Company UpdateOct 28, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExecutive Change · Shareholder VoteJun 13, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KMaterial Agreement · Reg FD DisclosureMar 20, 2025424B5424B5Mar 20, 2025424B5424B5Mar 19, 202510-K10-KMar 13, 20258-KResults of OperationsMar 13, 20258-KMaterial Agreement · New Debt / ObligationFeb 7, 20258-KReg FD Disclosure · Company UpdateJan 13, 2025SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GOct 22, 20248-KReg FD DisclosureOct 22, 20248-KMaterial AgreementOct 16, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KMaterial Agreement · Agreement TerminatedJul 11, 20248-KExecutive ChangeJun 24, 20248-KShareholder VoteJun 10, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KNew Debt / ObligationApr 23, 20248-KMaterial AgreementApr 16, 20248-KReg FD Disclosure · Company UpdateMar 28, 20248-KExecutive ChangeMar 15, 202410-K10-KMar 14, 20248-KResults of OperationsMar 14, 20248-KExecutive ChangeFeb 13, 20248-KMaterial Agreement · Agreement TerminatedJan 30, 20248-KExecutive ChangeJan 8, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KMaterial AgreementDec 18, 20238-KCompany UpdateNov 21, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KMaterial AgreementNov 2, 20238-KReg FD DisclosureOct 25, 20238-KExecutive ChangeOct 12, 20238-KReg FD DisclosureSep 26, 202310-Q10-QAug 28, 202310-K/A10-K/AAug 28, 20238-KResults of OperationsAug 25, 20238-KDelisting NoticeAug 17, 20238-KReg FD DisclosureAug 11, 20238-KExecutive ChangeAug 1, 20238-KReg FD Disclosure · Company UpdateJul 18, 20238-KExecutive ChangeJun 13, 20238-KExecutive Change · Shareholder VoteJun 8, 20238-KReg FD DisclosureJun 7, 20238-KCompany UpdateJun 2, 20238-KReg FD DisclosureMay 31, 20238-KReg FD Disclosure · Company UpdateMay 30, 20238-KMaterial Agreement · Reg FD DisclosureMay 25, 20238-KCompany UpdateMay 23, 20238-KDelisting NoticeMay 9, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023
Insider Activity
In the 90 days to Mar 4, 2026: 1 insider bought $87K · 6 sold $901K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Butler John P.CEO and President | Buy | 69,270 | $1.25 | $87K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 114,891 | $1.39 | $160K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 96,065 | $1.39 | $134K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 83,689 | $1.39 | $116K |
| Feb 2, 2026 | Grund NicholasChief Commercial Officer | Sell | 53,585 | $1.39 | $74K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 46,660 | $1.39 | $65K |
| Feb 2, 2026 | Malabre Richard CSVP, Chief Accounting Officer | Sell | 36,142 | $1.39 | $50K |
| Feb 2, 2026 | Ostrowski ErikSVP, CFO, CBO & Treasurer | Sell | 34,951 | $1.39 | $49K |
| Feb 2, 2026 | Grund NicholasChief Commercial Officer | Sell | 31,244 | $1.39 | $43K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 27,544 | $1.39 | $38K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 25,382 | $1.39 | $35K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 25,375 | $1.39 | $35K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 21,582 | $1.39 | $30K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 20,701 | $1.39 | $29K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 16,846 | $1.39 | $23K |
| Feb 2, 2026 | Malabre Richard CSVP, Chief Accounting Officer | Sell | 13,382 | $1.39 | $19K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance